Hyloris Pharmaceuticals ^Investors

Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company focused on addressing unmet medical needs. They specialize in reformulating well-known pharmaceuticals to develop innovative proprietary products that offer significant advantages compared to currently available alternatives. With a team led by Mr. Stefan Yee, who has over 30 years of experience in audit, corporate law, mergers and acquisitions, corporate finance, investment banking, and private equity, Hyloris Pharmaceuticals is committed to adding value to the healthcare system. They have achieved success by investing in and partnering with various listed and private companies in the pharmaceutical industry.